238 related articles for article (PubMed ID: 32849603)
1. PD-L1 Is Expressed and Promotes the Expansion of Regulatory T Cells in Acute Myeloid Leukemia.
Dong Y; Han Y; Huang Y; Jiang S; Huang Z; Chen R; Yu Z; Yu K; Zhang S
Front Immunol; 2020; 11():1710. PubMed ID: 32849603
[TBL] [Abstract][Full Text] [Related]
2. Acute Myeloid Leukemia Cells Express ICOS Ligand to Promote the Expansion of Regulatory T Cells.
Han Y; Dong Y; Yang Q; Xu W; Jiang S; Yu Z; Yu K; Zhang S
Front Immunol; 2018; 9():2227. PubMed ID: 30319662
[TBL] [Abstract][Full Text] [Related]
3. Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemia.
Zhou Q; Munger ME; Highfill SL; Tolar J; Weigel BJ; Riddle M; Sharpe AH; Vallera DA; Azuma M; Levine BL; June CH; Murphy WJ; Munn DH; Blazar BR
Blood; 2010 Oct; 116(14):2484-93. PubMed ID: 20570856
[TBL] [Abstract][Full Text] [Related]
4. Hyperfunction of CD4 CD25 regulatory T cells in de novo acute myeloid leukemia.
Wan Y; Zhang C; Xu Y; Wang M; Rao Q; Xing H; Tian Z; Tang K; Mi Y; Wang Y; Wang J
BMC Cancer; 2020 May; 20(1):472. PubMed ID: 32456622
[TBL] [Abstract][Full Text] [Related]
5. Elevated frequencies of CD4⁺ CD25⁺ CD127lo regulatory T cells is associated to poor prognosis in patients with acute myeloid leukemia.
Shenghui Z; Yixiang H; Jianbo W; Kang Y; Laixi B; Yan Z; Xi X
Int J Cancer; 2011 Sep; 129(6):1373-81. PubMed ID: 21105040
[TBL] [Abstract][Full Text] [Related]
6. Increased Regulatory T Cells in Peripheral Blood of Acute Myeloid Leukemia Patients Rely on Tumor Necrosis Factor (TNF)-α-TNF Receptor-2 Pathway.
Wang M; Zhang C; Tian T; Zhang T; Wang R; Han F; Zhong C; Hua M; Ma D
Front Immunol; 2018; 9():1274. PubMed ID: 29922294
[TBL] [Abstract][Full Text] [Related]
7. Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemia.
Shen W; Patnaik MM; Ruiz A; Russell SJ; Peng KW
Blood; 2016 Mar; 127(11):1449-58. PubMed ID: 26712908
[TBL] [Abstract][Full Text] [Related]
8. PD-L1 signal on liver dendritic cells is critical for Foxp3(+)CD4(+)CD25(+) Treg and liver tolerance induction in mice.
Liu H; Bakthavatsalam R; Meng Z; Li Z; Li W; Perkins JD; Reyes J
Transplant Proc; 2013 Jun; 45(5):1853-5. PubMed ID: 23769057
[TBL] [Abstract][Full Text] [Related]
9. B7-H1 up-regulation on dendritic-like leukemia cells suppresses T cell immune function through modulation of IL-10/IL-12 production and generation of Treg cells.
Ge W; Ma X; Li X; Wang Y; Li C; Meng H; Liu X; Yu Z; You S; Qiu L
Leuk Res; 2009 Jul; 33(7):948-57. PubMed ID: 19233469
[TBL] [Abstract][Full Text] [Related]
10. PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia model.
Zhang L; Gajewski TF; Kline J
Blood; 2009 Aug; 114(8):1545-52. PubMed ID: 19417208
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of CD200 is associated with Foxp3+ regulatory T cell expansion and disease progression in acute myeloid leukemia.
Memarian A; Nourizadeh M; Masoumi F; Tabrizi M; Emami AH; Alimoghaddam K; Hadjati J; Mirahmadian M; Jeddi-Tehrani M
Tumour Biol; 2013 Feb; 34(1):531-42. PubMed ID: 23179394
[TBL] [Abstract][Full Text] [Related]
12. Human CD8
Machicote A; Belén S; Baz P; Billordo LA; Fainboim L
Front Immunol; 2018; 9():2788. PubMed ID: 30555473
[TBL] [Abstract][Full Text] [Related]
13. Human Endothelial Cells Modulate CD4
Lim WC; Olding M; Healy E; Millar TM
Front Immunol; 2018; 9():565. PubMed ID: 29628925
[TBL] [Abstract][Full Text] [Related]
14. Enhanced Anti-Leukemic Effects through Induction of Immunomodulating Microenvironment by Blocking CXCR4 and PD-L1 in an AML Mouse Model.
Hwang HS; Han AR; Lee JY; Park GS; Min WS; Kim HJ
Immunol Invest; 2019 Jan; 48(1):96-105. PubMed ID: 30204524
[TBL] [Abstract][Full Text] [Related]
15. Role of regulatory T cells and checkpoint inhibition in hepatocellular carcinoma.
Langhans B; Nischalke HD; Krämer B; Dold L; Lutz P; Mohr R; Vogt A; Toma M; Eis-Hübinger AM; Nattermann J; Strassburg CP; Gonzalez-Carmona MA; Spengler U
Cancer Immunol Immunother; 2019 Dec; 68(12):2055-2066. PubMed ID: 31724091
[TBL] [Abstract][Full Text] [Related]
16. The altered PD-1/PD-L1 pathway delivers the 'one-two punch' effects to promote the Treg/Th17 imbalance in pre-eclampsia.
Zhang Y; Liu Z; Tian M; Hu X; Wang L; Ji J; Liao A
Cell Mol Immunol; 2018 Jul; 15(7):710-723. PubMed ID: 28890543
[TBL] [Abstract][Full Text] [Related]
17. PD-L1 Blockade Differentially Impacts Regulatory T Cells from HIV-Infected Individuals Depending on Plasma Viremia.
Peligero C; Argilaguet J; Güerri-Fernandez R; Torres B; Ligero C; Colomer P; Plana M; Knobel H; García F; Meyerhans A
PLoS Pathog; 2015 Dec; 11(12):e1005270. PubMed ID: 26633181
[TBL] [Abstract][Full Text] [Related]
18. In-vitro effect of pembrolizumab on different T regulatory cell subsets.
Toor SM; Syed Khaja AS; Alkurd I; Elkord E
Clin Exp Immunol; 2018 Feb; 191(2):189-197. PubMed ID: 28963773
[TBL] [Abstract][Full Text] [Related]
19. PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+ CD25(Hi) regulatory T cells.
Wang W; Lau R; Yu D; Zhu W; Korman A; Weber J
Int Immunol; 2009 Sep; 21(9):1065-77. PubMed ID: 19651643
[TBL] [Abstract][Full Text] [Related]
20. Molecular Markers of Regulatory T Cells in Cancer Immunotherapy with Special Focus on Acute Myeloid Leukemia (AML) - A Systematic Review.
Kaboli PJ; Zhang L; Xiang S; Shen J; Li M; Zhao Y; Wu X; Zhao Q; Zhang H; Lin L; Yin J; Wu Y; Wan L; Yi T; Li X; Cho CH; Li J; Xiao Z; Wen Q
Curr Med Chem; 2020; 27(28):4673-4698. PubMed ID: 31584362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]